Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23179659
Abstract: COVID-19, caused by the highly transmissible severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has rapidly spread and become a pandemic since its outbreak in 2019. We have previously discovered that aloperine is a new privileged scaffold… read more here.
Keywords: quinolizidines novel; entry; entry inhibitors; cov entry ... See more keywords